Pfizer’s Global Headquarters Relocation in NYC

Stroock represented pharmaceutical leader Pfizer Inc. as the anchor tenant in a recently signed 20-year office lease for its new global headquarters in the Hudson Yards section of Manhattan.

Pfizer will occupy over 800,000 square feet of space on 15 floors in The Spiral, a 2.8 million square foot tower being built by Tishman Speyer at 66 Hudson Boulevard.

Pfizer will relocate its global headquarters from 235 East 42nd Street to The Spiral and expects to begin occupancy in 2022. Stroock is also representing Pfizer in connection with the intended sale of its current headquarters on 42nd Street.

Pfizer Inc. operates as a pharmaceutical company. The Company, led by Ian C Read, Geoffrey M Levitt and Albert Bourla offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer, in 2017 recorded $53 Billion revenues.

The Stroock team representing Pfizer on the lease is led by Marc Hurel with Evan Babcock and Michael Zangara. The team representing Pfizer on the intended disposition is led by Joe Miller with Kelly Booker. Stroock tax support is provided by Mayer Greenberg and Brian Senie. Jeff Keitelman (Picture) leads the Stroock team, which regularly represents Pfizer in real estate transactions across the country.

Involved fees earner: Jeffrey R. Keitelman – Stroock; Evan Babcock – Stroock; Kelly Booker – Stroock; Marc Hurel – Stroock; Joseph Miller – Stroock; Michael Zangara – Stroock; Brian Senie – Stroock; Mayer Greenberg – Stroock;

Law Firms: Stroock;

Clients: Pfizer;

Print Friendly, PDF & Email

Author: Ambrogio Visconti